首页 | 本学科首页   官方微博 | 高级检索  
检索        


Renal cell carcinoma and end stage renal disease
Authors:Farivar-Mohseni Hesam  Perlmutter Adam E  Wilson Shandra  Shingleton W Bruce  Bigler Steven A  Fowler Jackson E
Institution:

1Division of Urology, University of Mississippi Medical Center, Jackson, Mississippi

2Division of Pathology, University of Mississippi Medical Center, Jackson, Mississippi

3Divisions of Urology, West Virginia University, Morgantown, West Virginia

4University of Colorado at Denver, Aurora, Colorado

5Louisiana State University at Shreveport, Shreveport, Louisiana

Abstract:PURPOSE: Patients with ESRD secondary to acquired renal cystic disease have been reported to have a higher incidence of RCC than the general population. We examined the clinical and pathological significance of incidental renal masses in patients with ESRD. MATERIALS AND METHODS: From January 1994 to July 2000, 852 consecutive patients with ESRD who were being considered for renal transplantation at University of Mississippi Medical Center were evaluated with renal ultrasound as part of assessment for possible kidney transplantation. Those patients with ultrasound suspicious for a malignant renal lesion were further evaluated with CT of the abdomen with and without intravenous contrast medium. Any patient with CT findings suspicious for RCC was recommended to undergo radical nephrectomy before kidney transplantation. RESULTS: A total of 19 patients had CT criteria for a possible malignant renal lesion. Seven patients had Bosniak class 3 renal cysts and 12 patients had solid, enhancing renal masses. Of the patients 17 underwent radical nephrectomy. On pathological examination 14 patients had RCC with a 1.64% prevalence in the population screened. Mean Fuhrman nuclear grade in our patients was 2.45. CONCLUSIONS: RCC in patients with ESRD are of clinical significance, considering the size, grade, histology and pathological stage of these tumors. The higher prevalence of clinically significant RCC in patients with ESRD as well as the risk of cancer progression while patients are on immunosuppressive medications justifies screening for RCC in patients with ESRD who are awaiting renal transplantation.
Keywords:kidney  carcinoma  renal cell  cysts  kidney failure  chronic  kidney transplantation
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号